Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Stéphanie Van Biervliet"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laurens Hermie, Stephanie Van Biervliet, Anne Hoorens, Lien Van Cauwenberghe, Eddy Robberecht, Luc Defreyne
Publikováno v:
Diagnostic and Interventional Radiology, Vol 30, Iss 1, Pp 55-64 (2024)
PURPOSE: Portal hypertension (PHT) and its sequelae are the most clinically important manifestations in cystic fibrosis-related liver disease (CFLD). This paper aimed to evaluate the safety and efficacy of a pre-emptive transjugular intrahepatic port
Externí odkaz:
https://doaj.org/article/b76d53dffa474c6abadd85fb11d0e658
Autor:
Levi Hoste, Agnieszka Prytula, Jo Dehoorne, Ruth De Bruyne, Stephanie Van Biervliet, Kathleen De Waele, Evelyn Maes, Victoria Bordon, Arnaud Vanlander, Karlien Claes, Johan Vande Walle, Petra Schelstraete, Sabine Van daele, Filomeen Haerynck
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundInfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is clinically diverse, and children have a low risk of developing severe coronavirus disease 2019 (COVID-19). However, children with chronic diseases have a potenti
Externí odkaz:
https://doaj.org/article/58cf0144150749c395ff9f99ffc308b4
Autor:
Pieter‐Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel, Stephanie Van Biervliet, Jan Van Bocxlaer, An Vermeulen, Elke Gasthuys
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 8, Pp 951-966 (2022)
Abstract Cystic fibrosis (CF) has been linked to altered drug disposition in various studies. However, the magnitude of these changes, influencing factors, and underlying mechanisms remain a matter of debate. The primary aim of this work was therefor
Externí odkaz:
https://doaj.org/article/8274e782a92e4d6d81b86237fa6c5c12
Autor:
Manon Kinaupenne, Marieke De Craemer, Heidi Schaballie, Kristof Vandekerckhove, Stephanie Van Biervliet, Heleen Demeyer
Publikováno v:
European Respiratory Review, Vol 31, Iss 165 (2022)
Cystic fibrosis (CF) is a life-shortening genetic disease, affecting multiple life domains including physical activity (PA). Although higher PA levels are associated with multiple health benefits, little insight exists on the PA level of people with
Externí odkaz:
https://doaj.org/article/0906c02f724f4688a7afec0274156ca5
Autor:
Marjolein M. Ensinck, Liesbeth De Keersmaecker, Anabela S. Ramalho, Senne Cuyx, Stephanie Van Biervliet, Lieven Dupont, Frauke Christ, Zeger Debyser, François Vermeulen, Marianne S. Carlon
Publikováno v:
ERJ Open Research, Vol 8, Iss 2 (2022)
Introduction Cystic fibrosis (CF) is a severe monogenic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Several types of CFTR modulators (correctors/potentiators) have been developed to overcome pr
Externí odkaz:
https://doaj.org/article/c24ba5ea7fe6417bbc0f22cc09e3e528
Autor:
Henk Groen, Gerard Dijkstra, Stephanie Van Biervliet, Edouard Louis, Jordi Guardiola, Patrick van Rheenen, Marleen Bouhuys, Willem S Lexmond, Triana Lobatón
Publikováno v:
BMJ Open, Vol 11, Iss 11 (2021)
Introduction Anti-tumour necrosis factor (TNF) therapy has greatly improved treatment outcomes in patients with inflammatory bowel disease (IBD), but long-term use is associated with cutaneous reactions, susceptibility to infections and frequent inje
Externí odkaz:
https://doaj.org/article/4eb4675afce34c889e8227c20153d47b
Publikováno v:
Biological Trace Element Research; Jul2003, Vol. 94 Issue 1, p33-40, 8p